- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/108 - EscherichiaKlebsiella
Patent holdings for IPC class A61K 39/108
Total number of patents in this class: 638
10-year publication summary
|
58
|
50
|
39
|
44
|
48
|
55
|
48
|
39
|
52
|
21
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1635 |
50 |
| Janssen Pharmaceuticals, Inc. | 429 |
42 |
| Pfizer Inc. | 3370 |
15 |
| Qu Biologics Inc. | 31 |
15 |
| Zoetis Services LLC | 1538 |
15 |
| Cornell University | 3288 |
14 |
| University of Maryland, Baltimore | 1009 |
14 |
| Sequoia Vaccines, Inc. | 14 |
12 |
| The United States of America as represented by the Secretary of the Navy | 2735 |
11 |
| Scandinavian Biopharma Holding AB | 18 |
10 |
| Northwestern University | 3366 |
8 |
| Board of Trustees of the University of Arkansas | 807 |
6 |
| The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | 365 |
6 |
| Vaxxinova US, Inc. | 50 |
6 |
| Idemitsu Kosan Co., Ltd. | 4166 |
5 |
| The Board of Trustees of the University of Illinois | 2686 |
5 |
| University of Southern California | 2109 |
5 |
| The Administrators of the Tulane Educational Fund | 392 |
5 |
| South Dakota State University | 73 |
5 |
| The Texas a & M University System | 1680 |
5 |
| Other owners | 384 |